drugset / Trial / NCT00775229
Naltrexone in the Treatment of Trichotillomania
RandomizedParallel-groupTriple-blindTreatment
Summary
This is an 8-week, double-blind study of Natrexone in the treatment of trichotillomania
Timeline
- Start
- 2008-08
- Primary completion
- 2012-11
- Completion
- 2012-12
Publications
- Hoffman J, Williams T, Rothbart R, Ipser JC, Fineberg N, Chamberlain SR, Stein DJ. Pharmacotherapy for trichotillomania. Cochrane Database Syst Rev. 2021 Sep 28;9(9):CD007662. doi: 10.1002/14651858.CD007662.pub3.
- Odlaug BL, Chamberlain SR, Harvanko AM, Grant JE. Age at onset in trichotillomania:clinical variables and neurocognitive performance. Prim Care Companion CNS Disord. 2012;14(4):PCC.12m01343. doi: 10.4088/PCC.12m01343. Epub 2012 Jul 19.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Naltrexone | Small molecule | 50 mg | Oral |
| Comparator | Naltrexone | Small molecule | 150 mg | Oral |